Advertisement
Despite offering assistance to individuals who cannot afford expensive medications

Copay Assist Programs Creating Problems in Health Care Markets

0
Despite offering assistance to those who cannot afford meds, programs create broader problems
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment

Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome

0
Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS
Most women newly diagnosed with breast cancer perceive high primary care provider (PCP) quality

Most Women Feel PCPs Are Involved in Breast Cancer Care

0
Overall, 66.2 and 69.1 percent of women perceive high PCP engagement and communication
Nivolumab is associated with longer overall survival than standard single-agent therapy in patients with platinum-refractory

Nivolumab Ups Overall Survival in Head, Neck Cancer

0
Longer overall survival compared with single-agent therapy for platinum-refractory squamous-cell cancer
The U.S. health care system is one of the least efficient worldwide based on a Bloomberg index that assesses life expectancy

U.S. Health Care System Is One of the Least Efficient Worldwide

0
America ranked 50 out of 55 countries in 2014, according to a Bloomberg index
Ribociclib plus letrozole is associated with significantly longer progression-free survival for patients receiving initial systemic treatment for hormone receptor-positive

Ribociclib + Letrozole Beneficial in Advanced Breast Cancer

0
Longer duration of progression-free survival in patients with HR+, HER2− breast cancer
For patients undergoing four selected inpatient operations

Variation in Medicare Payments for Peri-Op Complications

0
Large variation across hospitals for patients rescued from peri-op complications after four procedures
Treatment with tamoxifen or aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast

Long-Term Tamoxifen Does Lower Contralateral Breast Cancer Risk

0
Six-year study finds follow-up therapy cuts survivors' risk for cancer in the other breast
Adding daratumumab to standard treatment for advanced cases of multiple myeloma may significantly improve patients' chances of a response and even recovery

Adding Daratumumab to Standard Tx Effective in Multiple Myeloma

0
43.1 percent of study patients had a complete response
After adjusting for inflation

Price Increases Larger for Older Cancer Drugs Than Newer Ones

0
Older meds rose 22.7 percent in price, compared to a 6.2 percent increase for newer treatments